HRTS

TEMA CARDIO META ETF (HRTS)

About TEMA CARDIO META ETF (HRTS)

HRTS is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.

Details

Daily high
$27.69
Daily low
$27.39
Price at open
$27.60
52 Week High
$36.03
52 Week Low
$25.32
Market cap
53.2M
Dividend yield
1.71%
Volume
4,703
Avg. volume
10,798
P/E ratio
166.62
30-Day SEC yield
--
Expense Ratio (gross)
0.99%

TEMA CARDIO META ETF News

Details

Daily high
$27.69
Daily low
$27.39
Price at open
$27.60
52 Week High
$36.03
52 Week Low
$25.32
Market cap
53.2M
Dividend yield
1.71%
Volume
4,703
Avg. volume
10,798
P/E ratio
166.62
30-Day SEC yield
--
Expense Ratio (gross)
0.99%

Exchange Traded Funds (ETFs): Investors should carefully consider the information contained in the prospectus, which contains the Fund’s investment objectives, risks, charges, expenses, and other relevant information. You may obtain a prospectus from the Fund company’s website. Please read the prospectus carefully prior to investing.

Shares of ETFs must be bought and sold at market price, which can vary significantly from the Fund’s net asset value (NAV). Investment returns are subject to market volatility and shares may be worth more or less their original value when redeemed. The diversification of an ETF will not protect against loss. An ETF may not achieve its stated investment objective. Rebalancing and other activities within the fund may be subject to tax consequences.

Performance data quoted represents past performance. Past performance does not guarantee future results. Investment returns and principal value of an investment will fluctuate and when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the standardized performance data quoted. Select the Standardized Performance link for the latest quarterly performance.